What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study

American Psychiatric Association, 2000 American Psychiatric Association, 2013 Andreasen, 1982, Negative symptoms in schizophrenia: definition and reliability, Arch. Gen. Psychiatry, 39, 784, 10.1001/archpsyc.1982.04290070020005 Andreasen, 1982, Negative vs positive schizophrenia: definition and validation, Arch. Gen. Psychiatry, 39, 789, 10.1001/archpsyc.1982.04290070025006 Andreasen, 1995, Symptoms of schizophrenia: methods, meanings, and mechanisms, Arch. Gen. Psychiatry, 52, 341, 10.1001/archpsyc.1995.03950170015003 Andreasen, 2005, Remission in schizophrenia: proposed criteria and rationale for consensus, Am. J. Psychiatry, 162, 441, 10.1176/appi.ajp.162.3.441 Bilder, 1985, Symptomatic and neuropsychological components of defect states, Schizophr. Bull., 11, 409, 10.1093/schbul/11.3.409 Breier, 1991, National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome, Arch. Gen. Psychiatry, 48, 239, 10.1001/archpsyc.1991.01810270051007 Cella, 2016, Cognitive remediation for negative symptoms in schizophrenia, Clin. Psychol. Rev., 28, 43 Emsley, 2013, The nature of relapse in schizophrenia, BMC Psychiatry, 13, 50, 10.1186/1471-244X-13-50 Haro, 2014, Symptomatic remission and patient quality of life in an observational study of schizophrenia: is there a relationship?, Psychiatry Res., 220, 163, 10.1016/j.psychres.2014.07.034 Helldin, 2006, Remission and cognitive ability in a cohort of patients with schizophrenia, J. Psychiatr. Res., 40, 738, 10.1016/j.jpsychires.2006.07.005 Helldin, 2007, Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders, Schizophr. Res., 93, 160, 10.1016/j.schres.2007.01.014 Helldin, 2008, Experience of quality of life and attitude to care and treatment in patients with schizophrenia: role of cross-sectional remission, Int. J. Psychiatry Clin. Pract., 12, 97, 10.1080/13651500701660007 Helmes, 2003, Subtypes of schizophrenia: a cluster analytic approach, Can. J. Psychiatr., 48, 702, 10.1177/070674370304801010 Hjärthag, 2008, Psychometric properties of the burden inventory for relatives of persons with psychotic disturbances, Psychol. Rep., 12, 97 Hjortsberg, 2011, Costs for patients with psychotic illness: differences depending upon state of remission, J. Ment. Health Policy Econ., 14, 87 Ho, 1998, Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life, Am. J. Psychiatr., 155, 1196, 10.1176/ajp.155.9.1196 Kane, 2001, Progress defined-short-term efficacy, long-term effectiveness, Int. Clin. Psychopharmacol., 16, S1, 10.1097/00004850-200101001-00002 Kay, 1987, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophr. Bull., 13, 261, 10.1093/schbul/13.2.261 Kay, 1988, Reliability and validity of the positive and negative syndrome scale for schizophrenics, Psychiatry Res., 23, 99, 10.1016/0165-1781(88)90038-8 Kishimoto, 2013, Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies, J. Clin. Psychiatry, 74, 957, 10.4088/JCP.13r08440 von Knorring, 1992, The Swedish version of the positive and negative syndrome scale (PANSS) for schizophrenia: construct validity and interrater reliability, Acta Psychiatr. Scand., 86, 463, 10.1111/j.1600-0447.1992.tb03298.x Lasser, 2005, Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection, Schizophr. Res., 77, 215, 10.1016/j.schres.2005.03.006 Lasser, 2007, Remission in schizophrenia: applying recent consensus criteria to refine the concept, Schizophr. Res., 96, 223, 10.1016/j.schres.2007.05.003 Leucht, 2009, Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis, Lancet, 3, 31, 10.1016/S0140-6736(08)61764-X Liberman, 2002, Operational criteria and factors related to recovery from schizophrenia, Int. Rev. Psychiatry, 14, 256, 10.1080/0954026021000016905 Liddle, 1987, The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy, Br. J. Psychiatry, 151, 145, 10.1192/bjp.151.2.145 Liddle, 1989, Three syndromes in chronic schizophrenia, Br. J. Psychiatry Suppl., 7, 119, 10.1192/S0007125000291642 Lindström, 1994, Interrater reliability of the structured clinical interview for the positive and negative syndrome scale for schizophrenia, Acta Psychiatr. Scand., 89, 192, 10.1111/j.1600-0447.1994.tb08091.x Marchesi, 2014, Predictors of symptomatic remission in patients with first-episode schizophrenia: a 16years follow-up study, Compr. Psychiatry, 55, 778, 10.1016/j.comppsych.2013.12.011 Marchesi, 2015, Decrease of functioning in remitted and non-remitted patients 16 years after a first-episode schizophrenia, J. Nerv. Ment. Dis., 203, 406, 10.1097/NMD.0000000000000299 Marchesi, 2015, Severity of core symptoms in first episode schizophrenia and long-term remission, Psychiatry Res., 225, 129, 10.1016/j.psychres.2014.11.005 Möller, 2015, Pharmacological treatment of negative symptoms in schizophrenia, Eur. Arch. Psychiatry Clin. Neurosci., 265, 56, 10.1007/s00406-015-0596-y Müller, 1998, Improvement of inter-rater reliability of PANSS items and subscales by a standardized rater training, Acta Psychiatr. Scand., 98, 135, 10.1111/j.1600-0447.1998.tb10055.x van Os, 2006, Standardized remission criteria in schizophrenia, Acta Psychiatr. Scand., 113, 91, 10.1111/j.1600-0447.2005.00659.x van Os, 2006, Validation of remission criteria for schizophrenia, Am. J. Psychiatry, 163, 2000, 10.1176/ajp.2006.163.11.2000 Olsson, 2016, Predicting real-world functional milestones in schizophrenia, Psychiatry Res., 242, 1, 10.1016/j.psychres.2016.05.015 Overall, 1962, The brief psychiatric rating scale, Psychol. Rep., 10, 799, 10.2466/pr0.1962.10.3.799 Schneider, 2011, What happens to the voices? A fine-grained analysis of how hallucinations and delusions change under psychiatric treatment, Psychiatry Res., 188, 13, 10.1016/j.psychres.2010.12.013 Torgalsbøen, 2014, Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia, Psychiatry Res., 216, 1, 10.1016/j.psychres.2014.01.031